(2004) Death rate by the causes, 2004, Korea National Statistical Office

(1999) The National Survey of Lung Cancer in Korea,

(1998) New chemotherapeutic agents prolong survival and improve quality of life in non- small cell lung cancer:a review of the literature and future directions,

(2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer,

(2002) Lung cancer:time to move on from chemotherapy,

(2003) Molecular biology of lung cancer:clinical implications,

(2004) Targeting targeted therapy,

(2004) Molecular predictors of response to chemotherapy in lung cancer,

(2000) Lung cancer: principles and practice, Lippincott Williams & Willkins

(2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer,

(2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients,

(1998) Platinum-DNA adducts,nucleotide excision repair and platinum based anti-cancer chemotherapy,

(1994) Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy,

(2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer,

(2004) Association between polymorphism of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy,

(2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy,

(2002) An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer,

(2002) Expression of MAGE in the induced sputum of lung cancer patients,

(2004) Lung cancer detection by a RT-nested PCR using MAGE AS 1:6 common primers,

(1999) Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage,

(1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy,

(2001) ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy,

(2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer,

(2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I(except T1N0) II, and IIIa non- small-cell lung cancer,

(2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer,

(2004) Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery,

(2005) ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer,

(1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma,

(1994) Structure,chromosomal localization,and expression of 12 genes of the MAGE family,

(2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non small-cell lung cancer to gefitinib,